Telmo Llanga Selected Research

Uveitis

12/2019

AAV-mediated expression of HLA-G1/5 reduces severity of experimental autoimmune uveitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Telmo Llanga Research Topics

Disease

2	Inflammation (Inflammations) 09/2020 - 12/2019
2	Dysferlinopathy 03/2017 - 01/2017
1	Infections 01/2022
1	COVID-19 01/2022
1	Toxic Optic Neuropathy 09/2020
1	Uveitis 12/2019
1	Muscular Dystrophies (Muscular Dystrophy) 03/2017
1	Disease Progression 03/2017
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2017
1	Blindness (Hysterical Blindness) 02/2016
1	Mucopolysaccharidoses 02/2016

Drug/Important Bio-Agent (IBA)

2	Iduronidase (alpha-L-Iduronidase)IBA 09/2020 - 02/2016
2	Codon (Codons)IBA 09/2020 - 12/2019
2	DysferlinIBA 03/2017 - 01/2017
1	Toll-Like Receptor AgonistsIBA 01/2022
1	Nucleic AcidsIBA 01/2022
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	HLA-G Antigens (HLA G)IBA 12/2019
1	Protein Isoforms (Isoforms)IBA 12/2019
1	Complementary DNA (cDNA)IBA 01/2017

Therapy/Procedure

2	Therapeutics 03/2017 - 01/2017
1	Intravitreal Injections 12/2019
1	Transplantation 02/2016